Comparative morphometric study of immunohistochemical versus conventional staining for the evaluation of megakaryocytopoiesis in normal and pathological bone marrow biopsies

Pathology International

Volumn 47, Issue 5, 1997, Pages 301-307

  Marisavljević, Dragomir ^a   Radošević Radojković, Nina ^a   Rolović, Zoran ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

megakaryocytopoiesis; morphometry; myelodysplastic syndrome

Indexed keywords

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CANCER DIAGNOSIS; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MALE; MEGAKARYOPOIESIS; MORPHOMETRICS; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; STAINING;

EID: 0030951472     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1997.tb04497.x     Document Type: Article

References (28)

1. Levine R, Hazzard K, Lamberg J. The significance of megakaryocyte size. Blood 1982; 60: 1122-1131.
2. Harker L. Megakaryocyte quantification. J. Clin. Invest. 1968; 47: 452-458.
3. Erber W, Jacobs A, Oscier D, O'Hea A, Mason D. Circulating micromegakaryocytes in myelodysplasia. J. Clin. Pathol. 1987; 40: 1349-1352.
4. Tanum G, Gaudernack G. Small megakaryocytes: An identification problem. Res. Exp. Med. 1988; 188: 95-99.
5. Kawaguchi M, Nehashi Y, Aizawa S, Toyama K. Comparative study of immunocytochemical versus Giemsa stain for detecting dysmegakaryocytopoiesis in myelodysplastic syndrome (MDS). Eur. J. Haematol. 1990; 44: 89-93.
6. Kuriyama K, Tomonaga M, Matsuo T, Ginnai I, Ichimaru M. Diagnostic significance of detecting pseudo-Pelger-Huet anomalies and micromegakaryocytes in myelodysplastic syndrome. Br. J. Haematol. 1986; 63: 665-669.
7. Wiesneth M, Pflieger H, Kubanek B, Heimpel H. Micromegakaryocytes in human bone marrow. Acta Hematol. 1980; 64: 65-71.
8. Sato T, Shichishima T, Kimura H et al. Immunocytochemical detection of normal and abnormal megakaryocytes using monoclonal antibody to glycoprotein IIb/IIIa (TP 80): The quantitative assay in normal and leukemic patients. Scand. J. Haematol. 1986; 36: 415-423.
9. Fox S, Lorenzen J, Heryet A, Jones M, Gatter K, Mason D. Megakaryocytes in myelodysplasia: An immunohistochemical study on bone marrow trephines. Histopathology 1990; 17: 69-74.
10. Thiele J, Wagner S, Weuste R, Degel C, Dienemann D. An immunomorphometric study on megakaryocyte precursor cells in bone marrow tissue from patients with chronic myeloid leukemia (CML). Eur. J. Haematol. 1990; 44: 63-70.
11. Bennet J, Catovsky D, Daniel M et al. Proposal for the classification of the myelodysplastic syndrome. Br. J. Haematol. 1982; 51: 89-99.
12. Cordell J, Falini B, Erber W et al. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 1984; 32: 219-228.
13. Jackson C, Edwards C. Biphasic thrombocytopoietic response to severe hypobaric hypoxia. Br. J. Haematol. 1977; 35: 233-241.
14. Weibel E. Stereological methods. In: Practical Methods for Biological Morphometry, Vol. 1. Academic Press, London, 1979; 27-292.
15. Cullen M, McDonald T. Comparison of Stereological techniques for the quantification of megakaryocyte size and number. Exp. Hematol. 1986; 14: 782-788.
16. Weibel E, Gomez D. A principle for counting tissue structures on random sections. J. Appl. Physiol. 1962; 17: 343-348.
17. Abercrombie M. Estimation of nuclear population from microtomic sections. Anat. Rec. 1946; 94: 239-247.
18. Berkson J, Gage R. Calculation of survival rates for cancer. Mayo Clin. Proc. 1958; 25: 270-284.
19. Jandle J. Blood: Textbook of Hematology. Little, Brown and Co., Boston, 1987.
20. Jackson C, Dahl G. Relationship of megakaryocyte size at diagnosis to chemotherapeutic response in children with acute nonlymphocytic leukemia. Blood 1983; 61: 867-870.
21. Thiele J, Holgado S, Choritz H, Georgii A. Density distribution and size of megakaryocytes in inflammatory reactions of bone marrow (myelitis) and chronic myeloproliferative disease. Scand. J. Haematol. 1983; 31: 329-341.
22. Kobayashi Y, Kimura S, Tanaka K et al. Shift in the megakaryocyte ploidy in MDS patients: Microcytofluorimetry with DAPI staining after destaining of Wright-Giemsa stain. Br. J. Haematol. 1991; 79: 556-561.
23. Wong K, Chan J. Are 'dysplastic' and hypogranular megakaryocytes specific markers for myelodysplastic syndrome? Br. J. Haematol. 1991; 77: 509-514.
24. Brandt L, Leven G, Mitelman F, Sjogren U. Defective differentiation of megakaryocyte in acute leukemia. Acta Med. Scand. 1974; 196: 227-230.
25. Brody J, Krause J. Morphometric study of megakaryocyte size and prognosis in adults with acute leukemia. Leuk. Res. 1986; 10: 475-480.
26. Varella B, Chuang C, Woll J, Bennet J. Modification in the classification of primary myelodysplastic syndromes: The addition of a scoring system. Hematol. Oncol. 1985; 3: 55-63.
27. Jacobs A, Cornbleet M, Vardiman J, Larson R, LeBeau M, Rowley J. Prognostic implications of morphology and karyotype in primary myelodysplastic syndrome. Blood 1986; 67: 1765-1772.
28. Rios A, Canizo M, Sanz M et al. Bone marrow biopsy in myelodysplastic syndromes: Morphological characteristics and contribution to the study of prognostic factors. Br. J. Haematol. 1990; 75: 26-34.